1 / 30

Responsible Conduct of Research: Research Regulations

Responsible Conduct of Research: Research Regulations. Rachel Sheppard, MBA, CCRC, CCRA. Goals. Know the resources the University of Louisville offers to help you stay in compliance. Gain a basic understanding of the regulations governing clinical research.

Télécharger la présentation

Responsible Conduct of Research: Research Regulations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Responsible Conduct of Research: Research Regulations Rachel Sheppard, MBA, CCRC, CCRA

  2. Goals • Know the resources the University of Louisville offers to help you stay in compliance. • Gain a basic understanding of the regulations governing clinical research. • Learn to ask permission and not forgiveness.

  3. Investigator Responsibilities • Gain written IRB approval • Keep a research file and case report for each subject • Conduct study according to written protocol • Be knowledgeable about all interventions • Records of use of drug/device (accountability) • Personally supervise the investigation • Ensure proper billing as it relates to research

  4. Investigator Responsibilities (cont.) • Ensure subjects understand what is investigational about the protocol • Ensure all personnel are qualified/trained • Reporting any event that affects research to IRB • Ensure that IRB is compliant with regulations • Maintain approval of study • Record retention

  5. Training required • HIPAA fundamentals and security • CITI Biomedical Course • CITI GCP Training (recommended) • Annual SFI disclosure • Blood-borne pathogen Training • Basic Safety Laboratory Training (BSL 1/2) • Additional training

  6. Case Reports • Defined as medical information collected and presented on three or fewer patients to highlight an interesting treatment, presentation, or outcome • Authorization if identifiers are present (18 HIPAA) • Done without prior “research” intent • Does not meet the university definition of research • IRB review is required

  7. Observational research • Documents required • Complete Waiver • IRB application/approval • Protocol • Data collection forms • Billing Compliance Table (BCT) • Hospital approval (if applicable) • Retrospective or prospective research • If prospective, many other forms…similar to interventional research

  8. Interventional research • Documents required • Partial Waiver • Informed Consent Form • Protocol • Research Authorization • IRB application • IBC application (if applicable) • Data collection forms • Billing Compliance Table (BCT) • Hospital approval (if applicable) • If sponsored, many other forms…

  9. Documents for Screening and Enrollment • Informed Consent Form (ICF) • Research Authorization (RA) • Partial Waiver • Complete Waiver • What are these documents and their purpose? • Rule of 50 • Documentation of Consenting process

  10. Consent Documentation in Records • Name of person obtaining consent • Date of consent • A thorough discussion/explanation of the study was provided and with whom, i.e. subject family members, LAR. • Potential subject and/or LAR was allowed time to ask questions • All questions were answered • Potential subject verbalized understanding of the information provided • Subject or LAR agreed to participate in the study • Subject or LAR signed the ICF and Research Authorization • Study procedures were not performed prior to consent

  11. Goals/Responsibilities: Informed Consent Process • Give subject information about the research • Make sure there is adequate time • Determine ability to give informed consent • Cognitive status • Ability to read • Free of undue influence by others • Primary language spoken • Answer all questions • Determine understanding of subject • Obtain voluntary consent; free of coercion • Continue to inform subject

  12. Legally Authorized Representative • The individual that has the legal right to consent for the treatment/research • Kentucky State Statute • When to use • Protocol allow • IRB/local law • Call IRB for Guidance • Document, document, document!!!

  13. Re-consenting Reasons • Protocol changes • New safety information • New alternative treatments • Pediatric patient reaches 18 • Original consent process not done properly • Potential for capacity to consent may fluctuate • Substantial period since consent elapsed • Other changes mandated by IRB or sponsor

  14. Data collection guidelines • Always write with ink; not pencil • Record all data requested or indicate ND or NA • Only make justifiable changes by doing the following: • One line through entry • Record new value • Initial and date • Do not record data outside fields or write on the back • Record data on forms; not on napkins or scrubs • Try to collect specific data; not open-ended fill in the blank • Be consistent

  15. Protocol Violations • What is a protocol violation? • Reported based on major and minor • Major – Affects subject rights, safety, wellbeing and/or the completeness, accuracy and reliability of data

  16. Reportable to IRB • FDA, OHRP or other agency arrives/notifies for audit • Termination or suspension of research • SAEs/AEs • Protocol violations • New findings • Changes in personnel/procedures • DSMB reports • Breach of confidentiality of data • Incorrect labeling/dosing of test article

  17. Reportable to IRB • Discrepancy in accountability of test article • Unauthorized use of PHI • Subject complaints • Incarceration of a subject • Unexpected pregnancy of a subject or partner • Suicide attempt of subject while in research • Death of healthy volunteer within 30 days of participation • Injury of study personnel • Any problem that is unanticipated, related and affects the safety and welfare of subjects

  18. Billing Compliance Example • Examples of contingent procedure billing • Schedule of Events important tool

  19. What is purpose of HIPAA

  20. Using Health Information without Authorization • Treatment, Payment and Operations (TPO) • De-Identified Data • Limited data set with Data use agreement • Activities preparatory to research • Deceased Individuals • Waiver of authorization

  21. Waiver of Authorization • 45 CFR 164.512(i) • No more than minimal risk • Plan to protect identifiers • Destroy at earliest opportunity • PHI will not be reused or disclosed except by law • The research cannot be “practicably” conducted without waiver • The research cannot be “practicably” conducted without PHI

  22. Texting and Research • Very easy to violate the HIPAA regulations! • Privacy Office can advise on the use of Tigertext app

  23. Common IRB findings • Incorrect versions of stamped documents signed • Unapproved versions of documents signed • Lack of documentation of consent process • PI signature after time limit • Failure of PI to sign/date documentation • Incorrect/omitted signatures/dates on documents • LAR not well documented (identity, reason)

  24. More common findings • Lapse in IRB approval • Unreported SAEs/protocol violations • Assents signed by parents and not child • No re-consent of 18 year old • Personnel added to study without IRB approval • Missing source documentation • Enrollment numbers not accurate with IRB reports • Lack of policies and procedures for research conduct

  25. Governing Authorities for Research

  26. Federal Regulatory Agencies • DHHS overarching agency for the following: • FDA (device and drug research) • NIH (peer reviewed research) • OHRP (oversees both FDA and NIH research) • CMS (approval of billing for research procedures) • Code of Federal Regulations • Title 21, Food and Drugs • Title 45, Public Welfare • FDA has adopted ICH Guideline E6 Good Clinical Practice (recommendation) • Office of Civil Rights (enforces HIPAA regulations)

  27. Research Structure at UofL and HSC

  28. OCRSS assists in the approval process

  29. Resources • HSPPO Website http://louisville.edu/research/humansubjects • U of L Investigator Guide • Generic SOPs • ICF process documentation form • Auditors available for educational sessions • 24-hr Hotline: 1-877-852-1167 • Clinical Trial Networks website https://www.ctnbestpractices.org • FDA website http://fda.gov • Association of Clinical Research Professionals http://acrpnet.org • OCRSS Glossary of Terms (handout)

  30. Common Initialisms in Research

More Related